Lorlatinib (Lorviqua) is an oral kinase inhibitor primarily indicated for the treatment of specific types of non-small cell lung cancer (NSCLC). By inhibiting the abnormal activity of the ALK gene in tumor cells, the drug blocks tumor growth and spread, providing a crucial treatment option for patients with advanced lung cancer.
What Are the Indications for Lorlatinib (Lorviqua)?
Main Indications
(1) Lorlatinib is indicated for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) confirmed to be ALK-positive by an FDA-approved testing method.
(2) Treatment-Naive Patients: For ALK-positive metastatic NSCLC patients who have not received systemic therapy, lorlatinib can be used as a first-line treatment option.
(3) Previously Treated Patients: Lorlatinib also demonstrates favorable efficacy in patients whose disease has progressed after prior treatment with one or more ALK inhibitors (such as crizotinib, alectinib, etc.).
(4) It is important to note that the tumor must be confirmed as ALK-positive via a reliable testing method before lorlatinib administration to ensure treatment effectiveness.
Dosage Form, Strength and Appearance of Lorlatinib (Lorviqua)
Dosage Form, Strength and Appearance
(1) Lorlatinib is supplied as film-coated tablets in two different strengths to meet the dosage requirements of different patients.
(2) Each strength has distinct appearance and markings for easy identification and management.
(3) 25 mg tablet: This strength is an 8 mm round tablet, brownish in color, with "Pfizer" engraved on one side and "25" and "LLN" markings on the other side.
(4) 100 mg tablet: This strength is an 8.5 mm × 17 mm oval tablet, pale purple in color, with "Pfizer" engraved on one side and "LLN100" marking on the other side.
(5) Patients should swallow the tablets whole; do not chew, crush, or split them. Do not take any tablet that is broken, cracked, or incomplete.
Storage Method for Lorlatinib (Lorviqua)
Storage Conditions
(1) Storage Temperature: Lorlatinib should be stored at room temperature between 20°C and 25°C (68°F and 77°F). Short-term fluctuations between 15°C and 30°C (59°F and 86°F) are permitted.
(2) Environmental Requirements: The drug should be kept in its original packaging bottle, away from direct sunlight, moisture, and high-temperature environments.
(3) Safety Measures: Keep the drug out of the reach of children and pets. The bottle cap is designed to be child-resistant.
(4) Expiry Date and Disposal: Check the expiry date of the drug before use. Expired drugs should be disposed of promptly in accordance with local medication disposal guidelines to avoid environmental pollution or accidental use.
